These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11271591)

  • 1. [Misleading marketing concerning thrombosis survey].
    Lindmarker P
    Lakartidningen; 2001 Jan; 98(3):223-4. PubMed ID: 11271591
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
    André E; Hacquard M; Alnot Y; de Maistre E; Lecompte T
    Thromb Haemost; 2007 Sep; 98(3):693-4. PubMed ID: 17849066
    [No Abstract]   [Full Text] [Related]  

  • 3. Testing for genetic predisposition to venous thrombosis.
    Marques MB
    MLO Med Lab Obs; 2002 Jan; 34(1):8-13; quiz 20-1. PubMed ID: 11828956
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mali acroangiodermatitis in homozygous activated protein C resistance.
    Scholz S; Schuller-Petrovic S; Kerl H
    Arch Dermatol; 2005 Mar; 141(3):396-7. PubMed ID: 15781687
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of the introduction of the ProC Global assay in the screening strategy of protein C pathway abnormalities in unselected patients with a history of venous thromboembolism.
    Toulon P; Adda R; Perez P
    Thromb Haemost; 2001 Aug; 86(2):720-1. PubMed ID: 11522035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital and acquired activated protein C resistance.
    Nicolaes GA; Dahlbäck B
    Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use the entire "analysis package" when investigating patients with venous thrombosis! Don't forget the relatives...].
    Persson KE; Hillarp A; Lethagen S; Berntorp E; Dahlbäck B
    Lakartidningen; 2000 Nov; 97(47):5452-6. PubMed ID: 11192769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
    Gilmore R; Doyle M; Holden F; White B; O'Donnell J
    Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating idiopathic venous thromboembolism: what is necessary, what is not.
    Locke CF; Evans NC
    J Fam Pract; 2003 Oct; 52(10):770-7. PubMed ID: 14529600
    [No Abstract]   [Full Text] [Related]  

  • 15. [The routine coagulation tests along with activated protein C resistance (APC-R) in population of women applying for oral contraceptives].
    Kostecka I; Dabrowska M; Osada J; Suchowierska M; Wołczyński S
    Przegl Lek; 2001; 58(12):1038-40. PubMed ID: 12041017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status of hereditary hypercoagulability and cerebral venous thrombosis. Report of 3 cases].
    Guevara C; Nogales-Gaete J; Figueroa T; Sáez D; Valenzuela D
    Rev Med Chil; 2002 Jan; 130(1):79-85. PubMed ID: 11961966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiology patient page. Factor V Leiden.
    Ornstein DL; Cushman M
    Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
    [No Abstract]   [Full Text] [Related]  

  • 20. Deep venous thrombosis and thrombophilia: indications for testing and clinical implications.
    de Moerloose P; Alhenc-Gelas M; Boehlen F; Bounameaux H; Aiach M
    Semin Vasc Med; 2001; 1(1):89-96. PubMed ID: 15199518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.